Russell Investments Group
KYMR icon

Russell Investments Group’s Kymera Therapeutics KYMR Stock Holding History

Russell Investments Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14M Buy
62,233
+13,421
+27% +$1.15M 0.01% 1271
2026
Q1 		$4.07M Buy
48,812
+2,835
+6% +$224K ﹤0.01% 1473
2025
Q4 		$3.58M Buy
45,977
+26,986
+142% +$1.82M ﹤0.01% 1532
2025
Q3 		$1.07M Sell
18,991
-7,709
-29% -$348K ﹤0.01% 2176
2025
Q2 		$1.17M Sell
26,700
-55,807
-68% -$1.92M ﹤0.01% 1993
2025
Q1 		$2.26M Buy
82,507
+23,584
+40% +$860K ﹤0.01% 1624
2024
Q4 		$2.37M Sell
58,923
-860
-1% -$38.8K ﹤0.01% 1589
2024
Q3 		$2.83M Buy
59,783
+6,350
+12% +$280K ﹤0.01% 1503
2024
Q2 		$1.59M Buy
53,433
+1,676
+3% +$58K ﹤0.01% 1750
2024
Q1 		$2.08M Buy
51,757
+2,646
+5% +$94.7K ﹤0.01% 1630
2023
Q4 		$1.25M Buy
49,111
+17,999
+58% +$322K ﹤0.01% 1857
2023
Q3 		$432K Buy
31,112
+12,945
+71% +$260K ﹤0.01% 2278
2023
Q2 		$418K Sell
18,167
-9,773
-35% -$280K ﹤0.01% 2272
2023
Q1 		$828K Sell
27,940
-979
-3% -$31.6K ﹤0.01% 2061
2022
Q4 		$722K Buy
28,919
+5,944
+26% +$158K ﹤0.01% 2134
2022
Q3 		$498K Buy
22,975
+2,650
+13% +$69.8K ﹤0.01% 2247
2022
Q2 		$398K Buy
+20,325
New +$475K ﹤0.01% 2338
2021
Q4 		– Sell
-3,699
Closed -$217K – 3052
2021
Q3 		$217K Buy
+3,699
New +$214K ﹤0.01% 2751
2021
Q2 		– Sell
-24,684
Closed -$951K – 3260
2021
Q1 		$951K Buy
24,684
+19,705
+396% +$1.19M ﹤0.01% 2265
2020
Q4 		$357K Buy
+4,979
New +$243K ﹤0.01% 2556

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Russell Investments Group's KYMR Position: Q2 2026 in Review

Russell Investments Group increased its Kymera Therapeutics (KYMR) stake by 27% in Q2 2026, buying an estimated $1.15M and bringing the position to 62,233 shares worth $7.14M. The position accounts for 0.01% of the portfolio, ranked #1271.

Russell Investments Group first reported a position in KYMR in Q4 2020 and has held it in 20 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Russell Investments Group held 62,233 shares of Kymera Therapeutics worth $7.14M as of Q2 2026.
  • Russell Investments Group bought 13,421 Kymera Therapeutics shares in Q2 2026, an estimated $1.15M.
  • Kymera Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1271 holding.
  • Russell Investments Group first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.